Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
Conditions in which the primary symptom is HEADACHE and the headache cannot be attributed to any known causes.
The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
Conditions with HEADACHE symptom that can be attributed to a variety of causes including BRAIN VASCULAR DISORDERS; WOUNDS AND INJURIES; INFECTION; drug use or its withdrawal.
A primary headache disorder that is characterized by severe, strictly unilateral PAIN which is orbital, supraorbital, temporal or in any combination of these sites, lasting 15-180 min. occurring 1 to 8 times a day. The attacks are associated with one or more of the following, all of which are ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial SWEATING, eyelid EDEMA, and miosis. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
A common primary headache disorder, characterized by a dull, non-pulsatile, diffuse, band-like (or vice-like) PAIN of mild to moderate intensity in the HEAD; SCALP; or NECK. The subtypes are classified by frequency and severity of symptoms. There is no clear cause even though it has been associated with MUSCLE CONTRACTION and stress. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
Primary headache disorders that show symptoms caused by the activation of the AUTONOMIC NERVOUS SYSTEM of the TRIGEMINAL NERVE. These autonomic features include redness and tearing of the EYE, nasal congestion or discharge, facial SWEATING and other symptoms. Most subgroups show unilateral cranial PAIN.
Recurrent unilateral pulsatile headaches, not preceded or accompanied by an aura, in attacks lasting 4-72 hours. It is characterized by PAIN of moderate to severe intensity; aggravated by physical activity; and associated with NAUSEA and / or PHOTOPHOBIA and PHONOPHOBIA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
A medical specialty concerned with the study of the structures, functions, and diseases of the nervous system.
Neuralgic syndromes which feature chronic or recurrent FACIAL PAIN as the primary manifestation of disease. Disorders of the trigeminal and facial nerves are frequently associated with these conditions.
Decarboxylated monoamine derivatives of TRYPTOPHAN.
A primary headache disorder that is characterized by frequent short-lasting, unilateral, neuralgiform pain attacks in the ocular area, with CONJUNCTIVA fluid-filling and tearing. SUNCT syndrome is usually resistant to treatment.
Secondary headache disorders attributed to a variety of cranial or cervical vascular disorders, such as BRAIN ISCHEMIA; INTRACRANIAL HEMORRHAGES; and CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS.
Compounds capable of relieving pain without the loss of CONSCIOUSNESS.
Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.
A non-steroidal anti-inflammatory agent (NSAID) that inhibits the enzyme cyclooxygenase necessary for the formation of prostaglandins and other autacoids. It also inhibits the motility of polymorphonuclear leukocytes.
A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
Persistent and disabling ANXIETY.
Those disorders that have a disturbance in mood as their predominant feature.
Categorical classification of MENTAL DISORDERS based on criteria sets with defining features. It is produced by the American Psychiatric Association. (DSM-IV, page xxii)
Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.

A 14-year-old Nigerian female with idiopathic intracranial hypertension (Pseudotumor cerebri or benign intracranial hypertension). (1/37)

A 14-year-old secondary school girl presented with acute onset severe generalized headache associated with vomiting and diplopia. These followed an initial fever, which responded to chloroquine. She had been on peflacine for a left knee septic arthritis until onset of her symptoms. The main findings on physical examination were mild obesity, left abducent nerve palsy, bilateral papilledema and evidence of resolving arthritis of her left knee. The results of her investigations, including a brain CT scan were within normal limits. A diagnosis of IIH was made. She responded satisfactorily to oral acetazolamide with complete resolution of her symptoms and signs within 12 days of hospitalization and 2 weeks of follow-up.  (+info)

Nontraumatic headache in the Emergency Department: a survey in the province of Trieste. (2/37)

The objective was to study the demographics, diagnostic procedures and therapies employed in order to provide guidelines to Emergency Department (ED) physicians. A six-month retrospective analysis of the records of all patients presenting with nontraumatic headache (NTH) to the EDs of the Province of Trieste was performed. Of 38,238 patients screened, 300 (0.8%) presented with NTH and 49.7% were referred to specialists. Patients were classified as having secondary headache (41.3%), primary headache (24.3%) and headache with no obvious source (NOS) (34.4%). One hundred and seventy patients were treated with mono- or polytherapy. Of 50 patients with migraine, 36 were treated with NSAIDs and 4 with triptans. 68.4% of patients were referred to a general practitioner and 31.6% were admitted. The frequency of NTH was lower than in other studies. NOS headache was frequent. Only 10% of migraineurs received triptans. Diagnostic and therapeutic guidelines for ED physicians are needed.  (+info)

The prevalence of headache in Behcet's syndrome. (3/37)

OBJECTIVES: Behcet's syndrome is an uncommon systemic disorder that involves the nervous system in 5% of cases. Headache may arise in conjunction with such complications but also appears to occur independently. We sought to define the prevalence of headache in an unselected group of patients with Behcet's syndrome, to characterize the headache syndromes and to identify what treatments are being used. METHODS: A questionnaire was sent to an unselected group of patients through their support group newsletter. RESULTS: The results showed a prevalence of recurrent headache in 82.5% of responders; the majority exhibited symptoms that fulfilled the International Headache Society criteria for migraine, with a higher than normal prevalence of visual or sensory aura of 52%. Using the Migraine Disability Assessment (MIDAS) score for disability in migraine, 62% of responders showed moderate or severe disability. Headache treatment was poor, the majority of sufferers resorting to over-the-counter remedies; preventative treatments had rarely been prescribed. CONCLUSIONS: Recurrent headache is very common in Behcet's syndrome, is poorly treated and is associated with disablement.  (+info)

Topo-kinesthetic memory in chronic headaches. A new test for chronic patients: preliminary report. (4/37)

The objective of this study was to establish if chronic headaches with medication overuse can modify a topo-kinesthetic memory test. Nineteen patients with medication overuse headache (MOH), 13 patients with chronic tension-type headache (CTTH) without medication use and a group of "normal" subjects underwent a topo-kinesthetic memory test at T0 and after one month (T1); a control group of healthy volunteers was also tested to establish the baseline in our experimental setting. After one month, in the MOH patients there was a reduction of medication overuse from 3.3+/-2.65 to 1.1+/-2.23 (p<0.01), but no significant reduction in headache frequency and severity index, quality of life, anxiety and depression scores. The navigation time at T0 was 14.3+/-4.97, 27.9+/-10.12, 34.3+/-15.38 and 7.5+/-2.33, 10.1+/-2.95, 11.4+/-3.21 for control, MOH and CTTH with closed and open eyes, respectively (p<0.02). At T1, the MOH patients reached performances with open eyes similar to the healthy controls, while with closed eyes the navigation test reached times similar to those of CTTH patients. The topo-kinesthetic memory test seems both able to discriminate MOH and CTTH from healthy volunteers and to be related to pain scores but is not influenced by the use of drugs.  (+info)

Acute treatment of headache. (5/37)

Effective acute treatment of headache begins with making an accurate diagnosis and ruling out secondary causes of headache. Once a primary headache is diagnosed, it is important to choose the right combination of behavioural therapy and acute care (abortive and symptomatic) therapy for each patient. Some patients may need preventive medication on a daily basis. If patients overuse acute medications and develop medication overuse headache (previously called analgesic rebound headache), they often seek medical attention due to the chronicity and/or intensity of their pain and resultant disability. For acute care of migraine, physicians should choose a triptan they know and expect to work. They should prescribe the dose and route of administration that will provide the most rapid and complete response to all the associated symptoms of migraine, in addition to the pain. The effectiveness of the 7 available triptans in early, double-blind, controlled trials is more similar than different. How and when to give them will be discussed. Treatment of cluster headache will be presented briefly.  (+info)

The Acute Hangover Scale: A new measure of immediate hangover symptoms. (6/37)

PURPOSE: No psychometrically established measure of acute hangover symptoms is published and available to use in experimental investigations. The present investigation combined data across three studies of residual alcohol effects to establish the properties of a new Acute Hangover Scale (AHS) based on symptoms supported in previous lab studies. METHODS: Professional mariners from a Swedish maritime academy (n=54) and young adult students/recent graduates of urban U.S. universities (n=135) participated in one of three within-subjects' studies of residual effects of heavy drinking (M=0.114 g% breath alcohol concentration [BrAC]). All drank placebo one evening and alcoholic drinks another evening followed by an 8-h sleep period before completing the AHS 10-20 min after awakening. RESULTS: The AHS showed excellent internal consistency reliability the morning after alcohol. The AHS mean score and each item were significantly affected by beverage but not demographics or typical drinking, supporting validity. CONCLUSIONS: The AHS is a reliable and valid instrument for assessing acute hangover symptoms in experimental investigations of residual alcohol effects.  (+info)

Endocannabinoids in chronic migraine: CSF findings suggest a system failure. (7/37)

Based on experimental evidence of the antinociceptive action of endocannabinoids and their role in the modulation of trigeminovascular system activation, we hypothesized that the endocannabinoid system may be dysfunctional in chronic migraine (CM). We examined whether the concentrations of N-arachidonoylethanolamide (anandamide, AEA), palmitoylethanolamide (PEA), and 2-arachidonoylglycerol (2-AG) in the CSF of patients with CM and with probable CM and probable analgesic-overuse headache (PCM+PAOH) are altered compared with control subjects. The above endocannabinoids were measured by high-performance liquid chromatography (HPLC), and quantified by isotope dilution gas-chromatography/mass-spectrometry. Calcitonin gene-related peptide (CGRP) levels were also determined by RIA method and the end products of nitric oxide (NO), the nitrites, by HPLC. CSF concentrations of AEA were significantly lower and those of PEA slightly but significantly higher both in patients with CM and PCM+PAOH than in nonmigraineur controls (p<0.01 and p<0.02, respectively). A negative correlation was found between AEA and CGRP levels in CM and PCM+PAOH patients (r=0.59, p<0.01 and r=-0.65, p<0.007; respectively). A similar trend was observed between this endocannabinoid and nitrite levels. Reduced levels of AEA in the CSF of CM and PCM+PAOH patients may reflect an impairment of the endocannabinoid system in these patients, which may contribute to chronic head pain and seem to be related to increased CGRP and NO production. These findings support the potential role of the cannabinoid (CB)1 receptor as a possible therapeutic target in CM.  (+info)

The incidence and severity of hangover the morning after moderate alcohol intoxication. (8/37)

 (+info)

Headache disorders refer to a group of conditions characterized by recurrent headaches that cause significant distress and impairment in daily functioning. The most common types of headache disorders are tension-type headaches, migraines, and cluster headaches.

Tension-type headaches are typically described as a dull, aching sensation around the head and neck, often accompanied by tightness or pressure. Migraines, on the other hand, are usually characterized by moderate to severe throbbing pain on one or both sides of the head, often accompanied by nausea, vomiting, sensitivity to light and sound, and visual disturbances.

Cluster headaches are relatively rare but extremely painful, with attacks lasting from 15 minutes to three hours and occurring several times a day for weeks or months. They typically affect one side of the head and are often accompanied by symptoms such as redness and tearing of the eye, nasal congestion, and sweating on the affected side of the face.

Headache disorders can have a significant impact on quality of life, and effective treatment often requires a multidisciplinary approach that may include medication, lifestyle changes, and behavioral therapies.

Primary headache disorders are a group of headaches that are not caused by an underlying medical condition or structural problem. They are considered to be separate medical entities and include:

1. Migraine: A recurring headache that typically causes moderate to severe throbbing pain, often on one side of the head. It is commonly accompanied by nausea, vomiting, and sensitivity to light and sound.
2. Tension-type headache (TTH): The most common type of headache, characterized by a pressing or tightening sensation around the forehead or back of the head and neck. It is usually not aggravated by physical activity and does not cause nausea or vomiting.
3. Cluster headache: A rare but extremely painful type of headache that occurs in clusters, meaning they happen several times a day for weeks or months, followed by periods of remission. The pain is usually one-sided, centered around the eye and often accompanied by redness, tearing, and nasal congestion.
4. New daily persistent headache (NDPH): A type of headache that starts suddenly and persists every day for weeks or months. It can be similar to tension-type headaches or migraines but is not caused by an underlying medical condition.
5. Trigeminal autonomic cephalalgias (TACs): A group of primary headache disorders characterized by severe pain on one side of the head, often accompanied by symptoms such as redness, tearing, and nasal congestion. Cluster headaches are a type of TAC.
6. Other primary headache disorders: These include rare conditions such as hemicrania continua, paroxysmal hemicrania, and short-lasting unilateral neuralgiform headache attacks.

Primary headache disorders can significantly impact a person's quality of life and ability to function. Treatment typically involves medication, lifestyle changes, and behavioral therapies.

A headache is defined as pain or discomfort in the head, scalp, or neck. It can be a symptom of various underlying conditions such as stress, sinus congestion, migraine, or more serious issues like meningitis or concussion. Headaches can vary in intensity, ranging from mild to severe, and may be accompanied by other symptoms such as nausea, vomiting, or sensitivity to light and sound. There are over 150 different types of headaches, including tension headaches, cluster headaches, and sinus headaches, each with their own specific characteristics and causes.

A migraine disorder is a neurological condition characterized by recurrent headaches that often involve one side of the head and are accompanied by various symptoms such as nausea, vomiting, sensitivity to light and sound, and visual disturbances. Migraines can last from several hours to days and can be severely debilitating. The exact cause of migraines is not fully understood, but they are believed to result from a combination of genetic and environmental factors that affect the brain and blood vessels. There are different types of migraines, including migraine without aura, migraine with aura, chronic migraine, and others, each with its own specific set of symptoms and diagnostic criteria. Treatment typically involves a combination of lifestyle changes, medications, and behavioral therapies to manage symptoms and prevent future attacks.

Secondary headache disorders refer to headaches that are caused by an underlying medical condition, structural abnormality, or injury. These headaches can have various characteristics and patterns, and their symptoms may mimic those of primary headache disorders such as migraine or tension-type headaches. However, in order to diagnose a secondary headache disorder, the healthcare provider must identify and address the underlying cause.

Examples of conditions that can cause secondary headache disorders include:

* Intracranial hemorrhage (bleeding in the brain)
* Brain tumors or other space-occupying lesions
* Meningitis or encephalitis (infections of the membranes surrounding the brain or the brain itself)
* Sinusitis or other respiratory infections
* Temporomandibular joint disorder (TMJ)
* Giant cell arteritis (a condition that affects the blood vessels in the head and neck)
* Substance use or withdrawal (such as from caffeine or alcohol)
* Medications (such as nitroglycerin or blood pressure-lowering drugs)

It is important to note that secondary headache disorders can be serious and even life-threatening, so it is essential to seek medical attention if you experience a new or unusual headache, especially if it is accompanied by other symptoms such as fever, weakness, numbness, or difficulty speaking.

A cluster headache is a type of primary headache disorder characterized by severe, one-sided headaches that occur in clusters, meaning they happen several times a day for several weeks or months and then go into remission for a period of time. The pain of a cluster headache is typically intense and often described as a sharp, stabbing, or burning sensation around the eye or temple on one side of the head.

Cluster headaches are relatively rare, affecting fewer than 1 in 1000 people. They tend to affect men more often than women and usually start between the ages of 20 and 50. The exact cause of cluster headaches is not fully understood, but they are thought to be related to abnormalities in the hypothalamus, a part of the brain that regulates various bodily functions, including hormone production and sleep-wake cycles.

Cluster headache attacks can last from 15 minutes to several hours and may be accompanied by other symptoms such as redness or tearing of the eye, runny nose, sweating, or swelling on the affected side of the face. During a cluster period, headaches typically occur at the same time each day, often at night or in the early morning.

Cluster headaches can be treated with various medications, including triptans, oxygen therapy, and local anesthetics. Preventive treatments such as verapamil, lithium, or corticosteroids may also be used to reduce the frequency and severity of cluster headache attacks during a cluster period.

A tension-type headache (TTH) is a common primary headache disorder characterized by mild to moderate, non-throbbing head pain, often described as a tight band or pressure surrounding the head. The pain typically occurs on both sides of the head and may be accompanied by symptoms such as scalp tenderness, neck stiffness, and light or sound sensitivity.

TTHs are classified into two main categories: episodic and chronic. Episodic TTHs occur less than 15 days per month, while chronic TTHs occur 15 or more days per month for at least three months. The exact cause of tension-type headaches is not fully understood, but they are believed to be related to muscle tension, stress, anxiety, and poor posture.

Treatment options for TTHs include over-the-counter pain relievers such as ibuprofen or acetaminophen, relaxation techniques, stress management, physical therapy, and lifestyle modifications. In some cases, prescription medications may be necessary to manage chronic TTHs.

Trigeminal Autonomic Cephalalgias (TACs) is a group of primary headache disorders characterized by unilateral, severe head pain associated with ipsilateral cranial autonomic features. The International Classification of Headache Disorders, 3rd edition (ICHD-3) classifies TACs into four types:

1. Cluster Headache: Severe, strictly unilateral, orbital, supraorbital, or temporal pain lasting 15 minutes to three hours and occurring in clusters (usually at the same time of day for several weeks or months). The attacks are associated with ipsilateral cranial autonomic symptoms such as conjunctival injection, lacrimation, nasal congestion, rhinorrhea, forehead sweating, eyelid edema, and/or pupillary miosis.
2. Paroxysmal Hemicrania: Short-lasting (2-30 minutes) but recurrent attacks of severe unilateral head pain accompanied by ipsilateral cranial autonomic features. The attacks occur more than five times a day and are often associated with agitation or restlessness during the attack.
3. Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA): This category includes two subtypes: SUNCT (Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing) and SUNA (Short-lasting Unilateral Neuralgiform headache attacks with Autonomic symptoms). These disorders are characterized by moderate to severe unilateral head pain lasting 5 minutes to 6 hours, accompanied by cranial autonomic features.
4. Hemicrania Continua: A continuous, strictly unilateral headache of mild to moderate intensity with occasional exacerbations of severe pain. The attacks are associated with ipsilateral cranial autonomic symptoms and/or migrainous features such as photophobia, phonophobia, or nausea.

TACs are considered rare disorders, and their pathophysiology is not entirely understood. However, it is believed that they involve the trigeminal nerve and its connections to the brainstem. Treatment typically involves medications targeting the underlying mechanisms of these headaches, such as triptans for migraine-like features or anticonvulsants for neuralgiform pain. In some cases, invasive procedures like nerve blocks or neurostimulation may be considered.

"Migraine without Aura," also known as "Common Migraine," is defined by the International Classification of Headache Disorders (ICHD-3) as follows:

"Headaches fulfilling criteria C and D:

C. At least five attacks fulfilling criterion B

B. Headache lasting 4-72 hours (untreated or unsuccessfully treated)

1. a) Has at least two of the following characteristics:
b) One-sided location
c) Pulsating quality
d) Moderate or severe pain intensity
e) Aggravation by or causing avoidance of routine physical activity (e.g., walking or climbing stairs)

D. During headache at least one of the following:

1. a) Nausea and/or vomiting
2. b) Photophobia and phonophobia"

In simpler terms, Migraine without Aura is a recurring headache disorder characterized by moderate to severe headaches that typically occur on one side of the head, have a pulsating quality, and are aggravated by physical activity. The headaches last between 4 and 72 hours if not treated or if treatment is unsuccessful. Additionally, during the headache, at least one of the following symptoms must be present: nausea/vomiting, sensitivity to light (photophobia), or sensitivity to sound (phonophobia).

"Migraine with Aura" is a neurological condition that is formally defined by the International Classification of Headache Disorders (ICHD) as follows:

"An migraine attack with focal neurological symptoms that usually develop gradually over 5 to 20 minutes and last for less than 60 minutes. Motor weakness is not a feature of the aura."

The symptoms of an aura may include visual disturbances such as flickering lights, zigzag lines, or blind spots; sensory disturbances such as tingling or numbness in the face, arms, or legs; and speech or language difficulties. These symptoms are caused by abnormal electrical activity in the brain and typically precede or accompany a migraine headache, although they can also occur without a headache.

It's important to note that not all people who experience migraines will have an aura, and some people may have an aura without a headache. If you are experiencing symptoms of a migraine with aura or any other type of headache, it is recommended that you consult with a healthcare professional for proper diagnosis and treatment.

Neurology is a branch of medicine that deals with the study and treatment of diseases and disorders of the nervous system, which includes the brain, spinal cord, peripheral nerves, muscles, and autonomic nervous system. Neurologists are medical doctors who specialize in this field, diagnosing and treating conditions such as stroke, Alzheimer's disease, epilepsy, Parkinson's disease, multiple sclerosis, and various types of headaches and pain disorders. They use a variety of diagnostic tests, including imaging studies like MRI and CT scans, electrophysiological tests like EEG and EMG, and laboratory tests to evaluate nerve function and identify any underlying conditions or abnormalities. Treatment options may include medication, surgery, rehabilitation, or lifestyle modifications.

Facial neuralgia is a general term that refers to painful conditions affecting the facial nerves. It is often used to describe two specific disorders: trigeminal neuralgia and glossopharyngeal neuralgia.

1. Trigeminal neuralgia (TN), also known as tic douloureux, is a chronic pain condition that affects the trigeminal nerve, one of the major nerves of the face. The trigeminal nerve is responsible for sensations in the face and motor functions such as biting and chewing. Trigeminal neuralgia causes intense, stabbing, electric shock-like pain in the areas of the face where the branches of the nerve are distributed: the lower jaw, upper jaw, and cheek. The pain usually affects one side of the face, is triggered by light touch or other stimuli, and can last from a few seconds to several minutes.

2. Glossopharyngeal neuralgia (GPN) is a similar but less common condition that involves the glossopharyngeal nerve, which is responsible for sensations in the throat, tongue, and ear on one side of the face. GPN causes sharp, stabbing pain in these areas, often triggered by swallowing, talking, or coughing.

Both trigeminal neuralgia and glossopharyngeal neuralgia can be debilitating and significantly impact a person's quality of life. The exact cause of these conditions is not always clear, but they are often associated with nerve compression by blood vessels or tumors, age-related changes in the nerves and blood vessels, multiple sclerosis, or other underlying medical conditions. Treatment options may include medications to manage pain, surgical procedures to decompress the affected nerves, or, in some cases, radiofrequency ablation or gamma knife radiosurgery to destroy a portion of the nerve and reduce pain signals.

Tryptamines are a class of organic compounds that contain a tryptamine skeleton, which is a combination of an indole ring and a ethylamine side chain. They are commonly found in nature and can be synthesized in the lab. Some tryptamines have psychedelic properties and are used as recreational drugs, such as dimethyltryptamine (DMT) and psilocybin. Others have important roles in the human body, such as serotonin, which is a neurotransmitter that regulates mood, appetite, and sleep. Tryptamines can also be found in some plants and animals, including certain species of mushrooms, toads, and catnip.

SUNCT syndrome, an acronym for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing, is a rare and severe type of headache disorder. It is characterized by recurrent episodes of intense, one-sided (unilateral) head pain that typically lasts for a short duration (less than 5 minutes). The headaches are often described as stabbing or piercing and can be triggered by various stimuli such as touch, movement, or temperature changes.

In addition to the head pain, SUNCT syndrome is also associated with autonomic symptoms, including redness (conjunctival injection) and tearing of the eye on the same side as the headache. Other possible autonomic symptoms include sweating, nasal congestion, and pupil changes.

SUNCT syndrome can be challenging to diagnose and treat due to its rarity and severity. It is typically managed with a combination of medications, including anti-epileptic drugs, and in some cases, invasive procedures such as nerve blocks or neurostimulation may be considered.

A vascular headache is a type of headache that is primarily caused by disturbances in the blood vessels that supply blood to the brain and surrounding tissues. The two most common types of vascular headaches are migraines and cluster headaches.

Migraines are characterized by intense, throbbing pain on one or both sides of the head, often accompanied by nausea, vomiting, sensitivity to light and sound, and visual disturbances known as auras. They can last from several hours to days.

Cluster headaches, on the other hand, are characterized by severe, one-sided pain around the eye or temple that occurs in clusters, meaning they occur several times a day for weeks or months, followed by periods of remission. Cluster headaches are often accompanied by symptoms such as redness and tearing of the eye, nasal congestion, and sweating on the affected side of the face.

Other types of vascular headaches include toxic headaches caused by exposure to certain substances or drugs, and headaches associated with high blood pressure or other medical conditions that affect the blood vessels in the brain.

Analgesics are a class of drugs that are used to relieve pain. They work by blocking the transmission of pain signals in the nervous system, allowing individuals to manage their pain levels more effectively. There are many different types of analgesics available, including both prescription and over-the-counter options. Some common examples include acetaminophen (Tylenol), ibuprofen (Advil or Motrin), and opioids such as morphine or oxycodone.

The choice of analgesic will depend on several factors, including the type and severity of pain being experienced, any underlying medical conditions, potential drug interactions, and individual patient preferences. It is important to use these medications as directed by a healthcare provider, as misuse or overuse can lead to serious side effects and potential addiction.

In addition to their pain-relieving properties, some analgesics may also have additional benefits such as reducing inflammation (like in the case of nonsteroidal anti-inflammatory drugs or NSAIDs) or causing sedation (as with certain opioids). However, it is essential to weigh these potential benefits against the risks and side effects associated with each medication.

When used appropriately, analgesics can significantly improve a person's quality of life by helping them manage their pain effectively and allowing them to engage in daily activities more comfortably.

A questionnaire in the medical context is a standardized, systematic, and structured tool used to gather information from individuals regarding their symptoms, medical history, lifestyle, or other health-related factors. It typically consists of a series of written questions that can be either self-administered or administered by an interviewer. Questionnaires are widely used in various areas of healthcare, including clinical research, epidemiological studies, patient care, and health services evaluation to collect data that can inform diagnosis, treatment planning, and population health management. They provide a consistent and organized method for obtaining information from large groups or individual patients, helping to ensure accurate and comprehensive data collection while minimizing bias and variability in the information gathered.

Indomethacin is a non-steroidal anti-inflammatory drug (NSAID) that is commonly used to reduce pain, inflammation, and fever. It works by inhibiting the activity of certain enzymes in the body, including cyclooxygenase (COX), which plays a role in producing prostaglandins, chemicals involved in the inflammatory response.

Indomethacin is available in various forms, such as capsules, suppositories, and injectable solutions, and is used to treat a wide range of conditions, including rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout, and bursitis. It may also be used to relieve pain and reduce fever in other conditions, such as dental procedures or after surgery.

Like all NSAIDs, indomethacin can have side effects, including stomach ulcers, bleeding, and kidney damage, especially when taken at high doses or for long periods of time. It may also increase the risk of heart attack and stroke. Therefore, it is important to use indomethacin only as directed by a healthcare provider and to report any unusual symptoms or side effects promptly.

Bipolar disorder, also known as manic-depressive illness, is a mental health condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression). When you become depressed, you may feel sad or hopeless and lose interest or pleasure in most activities. When your mood shifts to mania or hypomania (a less severe form of mania), you may feel euphoric, full of energy, or unusually irritable. These mood swings can significantly affect your job, school, relationships, and overall quality of life.

Bipolar disorder is typically characterized by the presence of one or more manic or hypomanic episodes, often accompanied by depressive episodes. The episodes may be separated by periods of normal mood, but in some cases, a person may experience rapid cycling between mania and depression.

There are several types of bipolar disorder, including:

* Bipolar I Disorder: This type is characterized by the occurrence of at least one manic episode, which may be preceded or followed by hypomanic or major depressive episodes.
* Bipolar II Disorder: This type involves the presence of at least one major depressive episode and at least one hypomanic episode, but no manic episodes.
* Cyclothymic Disorder: This type is characterized by numerous periods of hypomania and depression that are not severe enough to meet the criteria for a full manic or depressive episode.
* Other Specified and Unspecified Bipolar and Related Disorders: These categories include bipolar disorders that do not fit the criteria for any of the other types.

The exact cause of bipolar disorder is unknown, but it appears to be related to a combination of genetic, environmental, and neurochemical factors. Treatment typically involves a combination of medication, psychotherapy, and lifestyle changes to help manage symptoms and prevent relapses.

A mental disorder is a syndrome characterized by clinically significant disturbance in an individual's cognition, emotion regulation, or behavior. It's associated with distress and/or impaired functioning in social, occupational, or other important areas of life, often leading to a decrease in quality of life. These disorders are typically persistent and can be severe and disabling. They may be related to factors such as genetics, early childhood experiences, or trauma. Examples include depression, anxiety disorders, bipolar disorder, schizophrenia, and personality disorders. It's important to note that a diagnosis should be made by a qualified mental health professional.

Anxiety disorders are a category of mental health disorders characterized by feelings of excessive and persistent worry, fear, or anxiety that interfere with daily activities. They include several different types of disorders, such as:

1. Generalized Anxiety Disorder (GAD): This is characterized by chronic and exaggerated worry and tension, even when there is little or nothing to provoke it.
2. Panic Disorder: This is characterized by recurring unexpected panic attacks and fear of experiencing more panic attacks.
3. Social Anxiety Disorder (SAD): Also known as social phobia, this is characterized by excessive fear, anxiety, or avoidance of social situations due to feelings of embarrassment, self-consciousness, and concern about being judged or viewed negatively by others.
4. Phobias: These are intense, irrational fears of certain objects, places, or situations. When a person with a phobia encounters the object or situation they fear, they may experience panic attacks or other severe anxiety responses.
5. Agoraphobia: This is a fear of being in places where it may be difficult to escape or get help if one has a panic attack or other embarrassing or incapacitating symptoms.
6. Separation Anxiety Disorder (SAD): This is characterized by excessive anxiety about separation from home or from people to whom the individual has a strong emotional attachment (such as a parent, sibling, or partner).
7. Selective Mutism: This is a disorder where a child becomes mute in certain situations, such as at school, but can speak normally at home or with close family members.

These disorders are treatable with a combination of medication and psychotherapy (cognitive-behavioral therapy, exposure therapy). It's important to seek professional help if you suspect that you or someone you know may have an anxiety disorder.

Mood disorders are a category of mental health disorders characterized by significant and persistent changes in mood, affect, and emotional state. These disorders can cause disturbances in normal functioning and significantly impair an individual's ability to carry out their daily activities. The two primary types of mood disorders are depressive disorders (such as major depressive disorder or persistent depressive disorder) and bipolar disorders (which include bipolar I disorder, bipolar II disorder, and cyclothymic disorder).

Depressive disorders involve prolonged periods of low mood, sadness, hopelessness, and a lack of interest in activities. Individuals with these disorders may also experience changes in sleep patterns, appetite, energy levels, concentration, and self-esteem. In severe cases, they might have thoughts of death or suicide.

Bipolar disorders involve alternating episodes of mania (or hypomania) and depression. During a manic episode, individuals may feel extremely elated, energetic, or irritable, with racing thoughts, rapid speech, and impulsive behavior. They might engage in risky activities, have decreased sleep needs, and display poor judgment. In contrast, depressive episodes involve the same symptoms as depressive disorders.

Mood disorders can be caused by a combination of genetic, biological, environmental, and psychological factors. Proper diagnosis and treatment, which may include psychotherapy, medication, or a combination of both, are essential for managing these conditions and improving quality of life.

The Diagnostic and Statistical Manual of Mental Disorders (DSM) is a publication of the American Psychiatric Association (APA) that provides diagnostic criteria for mental disorders. It is widely used by mental health professionals in the United States and around the world to diagnose and classify mental health conditions.

The DSM includes detailed descriptions of symptoms, clinical examples, and specific criteria for each disorder, which are intended to facilitate accurate diagnosis and improve communication among mental health professionals. The manual is regularly updated to reflect current research and clinical practice, with the most recent edition being the DSM-5, published in 2013.

It's important to note that while the DSM is a valuable tool for mental health professionals, it is not without controversy. Some critics argue that the manual medicalizes normal human experiences and that its categories may be too broad or overlapping. Nonetheless, it remains an essential resource for clinicians, researchers, and policymakers in the field of mental health.

Major Depressive Disorder (MDD), also simply referred to as depression, is a serious mental health condition characterized by the presence of one or more major depressive episodes. A major depressive episode is a period of at least two weeks during which an individual experiences a severely depressed mood and/or loss of interest or pleasure in nearly all activities, accompanied by at least four additional symptoms such as significant changes in appetite or weight, sleep disturbances, psychomotor agitation or retardation, fatigue or loss of energy, feelings of worthlessness or excessive guilt, difficulty thinking, concentrating, or making decisions, and recurrent thoughts of death or suicide.

MDD can significantly impair an individual's ability to function in daily life, and it is associated with increased risks of suicide, substance abuse, and other mental health disorders. The exact cause of MDD is not fully understood, but it is believed to result from a complex interplay of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of psychotherapy (such as cognitive-behavioral therapy) and medication (such as selective serotonin reuptake inhibitors or tricyclic antidepressants).

It was defined as a secondary headache, with the aim of emphasising excessive drug intake as the basis of this form of headache ... Medication overuse headache is a recognized ICHD (International Classification of Headache Disorders) classification. Over the ... The International Headache Society. Retrieved 28 June 2014. "The International Classification of Headache Disorders". ihs- ... They typically occur in patients with an underlying headache disorder such as migraine or tension-type headache that " ...
Overview of Headache - Explore from the MSD Manuals - Medical Consumer Version. ... see table Some Causes and Features of Headaches Some Causes and Features of Headaches ). Some secondary headache disorders are ... headaches are due to a less common primary headache disorder called cluster headache Cluster Headaches A cluster headache ... Secondary headaches may result from disorders of the brain, eyes, nose, throat, sinuses, teeth, jaws, ears, or neck or from a ...
Most headache types, including primary headaches do not demonstrate specific definitive findings. Secondary headaches, however ... often demonstrate a causative factor for the headaches on neuroimaging. ... The objective of this course is to demonstrate the radiographic findings related to various headache types. ... Most headache types, including primary headaches do not demonstrate specific definitive findings. Secondary headaches, however ...
Guideline] The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004. Suppl 1:9-160. [QxMD MEDLINE ... Superior ophthalmic vein thrombosis secondary to COVID-19: an index case. Radiology Case Reports. 2021 MAY. 16:1138-1143. [Full ... which characterizes the onset of this disorder. Ophthalmoparesis or disordered eye movements occur when cranial nerves III, IV ... The disorder is rare during the first 2 decades of life; in people older than 20 years, it appears to have an even distribution ...
Secondary headaches can occur due to congestion, stress, and more. ... Getting the flu may trigger a migraine headache if you already have a headache disorder. ... Headache disorders. (2016).. https://www.who.int/news-room/fact-sheets/detail/headache-disorders. ... Secondary headaches are common flu symptoms, but these should not be debilitating. Normally, headache as a flu symptom resolves ...
The secondary effects of thiabendazole, principally gastrointestinal disorders, headache, and dizziness are underlined. SN - ... The secondary effects of thiabendazole, principally gastrointestinal disorders, headache, and dizziness are underlined. ...
Discover the effectiveness of MRI in diagnosing neurological disorders compared to CT scans. Findings reveal MRI as a superior ... a neurological disorder is the root cause of secondary headaches. These organic diseases may range from extracranial benign ... The Role of Neuroimaging in the Diagnosis of Headache Disorders. Therapeutic Advances in Neurological Disorders, 6, 369-374. ... MRI is considered one of the best imaging techniques for the optimal management of secondary headaches [4]. The discrimination ...
Without early and effective treatment, EM may progress to CM, and subsequently to MOH, a severe secondary headache disorder, ... Commenting on the study for Medscape, Christine Lay, MD, a director of the Canadian Headache Society, called it "a critically ... Patients with chronic migraine (CM) and patients with medication overuse headache (MOH) tend to overutilize acute pain ... is a professor of neurology at the University of Toronto and director of the Centre for Headache at Womens College Hospital in ...
Secondary glaucoma is glaucoma that is caused by previous or existing conditions or issues. Learn more about its possible ... Doctors prescribe topiramate to treat seizure disorders and to prevent migraine headaches. It is also used to treat neuropathic ... Causes of secondary glaucoma. Glaucoma is an eye disease that develops when eye pressure damages the optic nerve. In secondary ... Types of secondary glaucoma. Also like primary glaucoma, the two main types of secondary glaucoma are open angle and angle ...
This stress can lead to many downfalls like eating disorders, health issues, headaches, and even suicide. Research shows that ... is the most stressful due to the difficult college application process and at the same time being able to make post-secondary ... school seniors go through due to the unpleasant college application process and being able to make effective post secondary ...
Our primary outcome was the association between primary headache disorders and persistent LBP. Our secondary outcomes were any ... and the relationship between specific headache sub-types classified as per International Classification of Headache Disorders ( ... We identified a positive association between persistent LBP and primary headache disorders. The quality of the review findings ... Only two studies presented data investigating persistent LBP and chronic headache disorders in accordance with ICDH criteria. ...
... the EP must be well versed in treating common primary headache disorders, as proper management of the natural course of the ... Headaches comprise 3% of emergency department chief complaints.[1] While most headaches are benign (96%), recognizing less ... In addition to diagnosing and managing life-threatening causes of headaches, ... common, emergent causes of headaches is critical, as a timely intervention may be life-saving.[2] The primary role of the ...
... or other trigeminal autonomic cephalalgia secondary headache disorders. *Subject has known hypersensitivity or contraindication ... Subject has more than one migraine headache day per week on average by history - headache day defined as: headache that meets ... Subjects symptoms meet International Classification of Headache Disorders - 3 (ICHD-3) Diagnostic Criteria for migraine with ... Subject has known organic issues which may cause headaches (e.g., temporo-mandibular joint, brain tumor, cervical spinal issues ...
1) Children and adolescents with significant chronic medical illness: Central Nervous systen (secondary headache disorder other ... New daily persistent headache (NDPH) is a primary headache disorder characterized by the daily and unremitting headache pain ... New daily persistent headache (NDPH) is a primary headache disorder characterized by continuous pain experienced for at least 3 ... 1) Patients meeting clinical International Classification of Headache Disorders (ICHD-3 )classification for NDPH 2) Age 10-17 ...
Guideline] The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004. Suppl 1:9-160. [QxMD MEDLINE ... Superior ophthalmic vein thrombosis secondary to COVID-19: an index case. Radiology Case Reports. 2021 MAY. 16:1138-1143. [Full ... which characterizes the onset of this disorder. Ophthalmoparesis or disordered eye movements occur when cranial nerves III, IV ... The disorder is rare during the first 2 decades of life; in people older than 20 years, it appears to have an even distribution ...
The secondary aims of this study - among those reviews which were registered - are to identify: (1) how many primary outcomes ... identify the number of SRs prospectively registered in headache and migraine disorders within PROSPERO or in a scientific ... Method To locate published migraine and headache SR protocols, the following electronic databases will be searched: MEDLINE ( ...
Patrick L. Headache and acute cerebrovascular disease: How do we differentiate primary and secondary headache disorders in the ... For patients with acute ischemic cerebrovascular disease (within 48 h of onset), aspirin has been proven to reduce secondary ... disorders, effectively reducing plasma levels of total cholesterol, triglycerides and low-density lipoprotein, and exerting a ... Targeted proteomics improves cardiovascular risk prediction in secondary prevention. Eur Heart J 2022;43(16):1569-77. [Crossref ...
The main ALD sign was fever (90.8%, 109/120). Headaches and digestive disorders were more associated with dengue fever (odds ... All malaria patients recovered after a 3-day course of artenimol/piperaquine and secondary treatment with primaquine treatment ... Secondary infection developed in 4 patients with chikungunya (1 case each of pneumonia, dysentery, herpetic recurrence, and ... and 3 had secondary infections including acute pneumonia, Escherichia coli pyelonephritis, and intestinal amoebiasis. No ...
Introduction: Melatonin has been studied in headache disorders. Amitriptyline is efficacious for migraine prevention, but its ... The primary outcome was the number of migraine headache days per month at baseline versus last month. Secondary end points were ... Results: Mean headache frequency reduction was 2.7 migraine headache days in the melatonin group, 2.2 for amitriptyline and 1.1 ... Melatonin significantly reduced headache frequency compared with placebo (p=0.009), but not to amitriptyline (p=0.19). ...
The latest (2018) International Classification of Headache Disorders-3 (ICHD3) lays out three etiological categories of ... Secondary TNs may also be an indication for neuroablative therapies of the gasserian ganglion. In addition, trigeminal ganglion ... Similarly, they have also been found to have a role in the treatment of chronic intractable cluster headaches3,4 and persistent ... Perioperative and Outpatient Management of Patients with Substance Use Disorder Symposium * Register ...
... or vertigo have trouble getting a diagnosis for their particular vestibular disorder. ... Development of secondary conditions related to anxiety or conditioned responses can cause prolongation of symptoms once the ... These migraine symptoms occur usually in patients who have known migraine headaches but may not be accompanied by the typical ... MANY DIFFERENT DISORDERS CAN CAUSE DIZZINESS.. 80% of patients with the symptom of vertigo have an inner ear disorder. ...
Secondary Headache Disorders Medicine & Life Sciences 31% * Posterior Leukoencephalopathy Syndrome Medicine & Life Sciences 29% ... Patients with SCD and primary headache disorders may benefit from comprehensive headache treatment plans that include abortive ... Patients with SCD and primary headache disorders may benefit from comprehensive headache treatment plans that include abortive ... Patients with SCD and primary headache disorders may benefit from comprehensive headache treatment plans that include abortive ...
Secondary headaches comprise approximately 10% of all headache cases. They often have a serious underlying condition that needs ... Neuroimaging of headaches attributed to cranial and/or cervical vascular disorders. By admin Posted in abstracts ... home abstracts Neuroimaging of headaches attributed to cranial and/or cervical vascular disorders ... diagnostic methods can be utilized in the diagnostics of headaches attributed to cranial and cerebral vascular disorders which ...
Heres what may be causing your headache, and how to treat it. ... You can have headaches in different locations like behind the ... Secondary headaches. (2016).. https://americanmigrainefoundation.org/resource-library/secondary-headaches/. *. Spigt M, et al ... 2019). Primary headache disorders: Five new things. DOI:. http://doi.org/10.1212/CPJ.0000000000000654. ... Haaalp! Why Do I Have a Constant Headache?. Chronic daily headache is a persistent headache that happens at least 15 days out ...
Headache Classification Committee of the International Headache S. The International Classification of Headache Disorders, 3rd ... The primary outcome was the number of migraine headache days per month at baseline versus last month. Secondary end points were ... at least three migraine headache attacks or four migraine headache days (defined as any occurrence of migraine headache pain of ... Potential therapeutic use of melatonin in migraine and other headache disorders. Expert Opin Investig Drugs 2006;15:367-75. doi ...
... worsening of schizoaffective disorder, headache and nasopharyngitis, which is the common cold. ... In the trial, key secondary endpoint of improving and maintaining patient functioning were also met. ... Schizoaffective disorder is a mental condition characterised by a loss of contact with reality psychosis and mood symptoms of ... Invega Sustenna is the first long-acting injection to be evaluated for treatment of schizoaffective disorder and and if ...
Secondary Headache Disorders 75% * Patient Education 50% * Migraine Disorders 49% * Placebos 33% ... Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder. Singh-Tan, S., Torres-Lockhart, K., ... Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for ...
A majority of the children presented for evaluation of headache complaints, will have one of the primary headache disorder such ... Most of the presenting headaches are secondary to viral illnesses followed by primary headache and migraine. A detailed initial ... The purpose of this article is to review the spectrum of secondary headaches. In majority of the instances, a thorough medical ... Headache is a common symptom in childhood and adolescence. Effective therapy for this symptom is based on the specific headache ...
secondary headache disorders*these include a new headache occurring with another lesion capable of causing it.( e.g., headache ... headache disorders are classified by the ICHD-III as (1)*primary headache disorders: *migraine ... migraine is a common disabling primary headache disorder *migraine is the second most prevalent neurologic disorder (after ... 1)Headache Classification Committee of the International Headache Society (IHS). The international classification of headache ...

No FAQ available that match "headache disorders secondary"

No images available that match "headache disorders secondary"